Psychedelic Science & Me: Amanda Feilding

Psychedelic substances offer profound ways to alter consciousness and address various human illnesses. Scientific exploration into these states expands the understanding of consciousness itself while revealing new avenues for clinical treatment. Because these substances enhance creativity, spirituality, and personal transformation, the ethical and academic pursuit of their therapeutic potential remains a critical endeavor. Current research initiatives at the Beckley Foundation utilize advanced brain imaging like fMRI and MEG to examine psilocybin. Other studies, such as the collaboration with Johns Hopkins University, specifically investigate the utility of psilocybin as an aid in psychotherapy for addiction. Furthermore, MDMA is evaluated as a potential therapeutic tool, aiming to document the evidence for its clinical efficacy.